89579-74-8

Basic information

• Product Name: 4-HYDROXY-TETRAHYDRO-2-FUROIC ACID
• Synonyms: 4-HYDROXY-TETRAHYDRO-2-FUROIC ACID
• CAS NO: 89579-74-8
• Molecular Formula: C5H8O4
• Molecular Weight: 132.11
• Mol File: 89579-74-8.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-HYDROXY-TETRAHYDRO-2-FUROIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 4-HYDROXY-TETRAHYDRO-2-FUROIC ACID(89579-74-8)
• EPA Substance Registry System: 4-HYDROXY-TETRAHYDRO-2-FUROIC ACID(89579-74-8)

Safety Data

• Hazardous Substances Data: 89579-74-8(Hazardous Substances Data)

Upstream product

• 2209-07-6 3-Hydroxy-5,5-tetrahydrofurandicarbonsaeure 
• 2209-06-5 2-(2,3-dihydroxypropyl)propanediamide 

Downstream Products

• 2208-93-7 trans-4-Hydroxy-tetrahydrofuran-carbonsaeure-⁽²⁾-methylester 
• 91020-98-3 methyl cis-4-tosyloxytetrahydrofuran-2-carboxylate 
• 91021-04-4 trans-4-(N-tosylamino)tetrahydrofuran-2-carboxylic acid 
• 785044-07-7 (2R,4S)-4-Amino-tetrahydro-furan-2-carboxylic acid methyl ester 
• 91021-02-2 trans-4-aminotetrahydrofuran-2-carboxylic acid 
• 91020-98-3 methyl trans-4-tosyloxytetrahydrofuran-2-carboxylate 
• 91021-04-4 (+/-)-cis-4-(4-methylphenylsulfonamido)tetrahydrofuran-2-carboxylic acid 
• 785044-07-7 (2R,4R)-4-Amino-tetrahydro-furan-2-carboxylic acid methyl ester 
• 91021-02-2 cis-4-aminotetrahydrofuran-2-carboxylic acid 
• 91021-06-6 N-tosyl-2-oxa-5-azabicyclo<2.2.1>heptan-6-one 
• 2208-93-7 (2R,4R)-4-Hydroxy-tetrahydro-furan-2-carboxylic acid methyl ester 
• 2208-93-7 (2R,4S)-4-Hydroxy-tetrahydro-furan-2-carboxylic acid methyl ester 

Relevant articles and documents

SULPHAMOYL UREA DERIVATIVES CONTAINING ALKYL-OXACYCLOALKYL MOIETY AND USES THEREOF

The present disclosure relates to compounds of Formula (I): and to their pharmaceutically acceptable salts, pharmaceutical compositions, methods of use, and methods for their preparation. The compounds disclosed herein are useful for inhibiting the maturation of cytokines of the IL-1 family by inhibiting inflammasomes and may be used in the treatment of disorders in which inflammasome activity is implicated, such as inflammatory, autoinflammatory and autoimmune diseases and cancers.